Cargando…

NS-64: Lessons learned: patient management and outcomes of Multiple Myeloma patients during the COVID-19 pandemic in New York City

New York City (NYC) was an epicenter of COVID-19 pandemic in the United States during spring 2020. During March–May 2020, approximately 203,000 confirmed COVID-19 cases were reported among NYC residents including 54,211 (26.6%) known to have been hospitalized and 18,679 (9.2%) who died. NYC had a hi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Catamero, Donna, Van Oekelen, Oliver, Mouhieddine, Tarek, Wang, Bo, Metzger, Megan, Richter, Joshua, Chari, Ajai, Verina, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	Poster Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580190/ http://dx.doi.org/10.1016/S2152-2650(21)02358-2

Ejemplares similares

NP-114: Lesson Learned: Management of patients with Multiple Myeloma (MM) and their response to two doses of COVID-19 RNA vaccine
por: Verina, Daniel, et al.
Publicado: (2021)

A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward
por: Wang, Bo, et al.
Publicado: (2020)

A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward
por: Wang, Bo, et al.
Publicado: (2020)

MM-239: A Tertiary Center Experience of Multiple Myeloma Patients with COVID-19: Lessons Learned and the Path Forward
por: Wang, Bo, et al.
Publicado: (2020)

Novel Treatments for Patients With Relapsed/Refractory Multiple Myeloma
por: Rodriguez, Cesar, et al.
Publicado: (2023)

Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma
por: Van Oekelen, Oliver, et al.
Publicado: (2021)

Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma
por: Mouhieddine, Tarek H., et al.
Publicado: (2022)

OAB-048: Suboptimal humoral immune response to SARS-CoV-2 mRNA vaccination in myeloma patients is associated with anti-CD38 mAb and BCMA-targeted treatment
por: Oekelen, Oliver Van, et al.
Publicado: (2021)

Subcutaneous daratumumab and hyaluronidase-fihj in newly diagnosed or relapsed/refractory multiple myeloma
por: Sanchez, Larysa, et al.
Publicado: (2021)

P876: INCIDENTAL DISCOVERY OF PROBABLE PATHOGENIC GERMLINE VARIANTS IN MULTIPLE MYELOMA PATIENTS UNDERGOING SOMATIC GENOMIC PROFILING
por: Thibaud, S., et al.
Publicado: (2022)

Selinexor in relapsed/refractory multiple myeloma
por: Richter, Joshua, et al.
Publicado: (2020)

A Focus on CAR T-Cell Therapy and Bispecific Antibodies in Multiple Myeloma
por: Catamero, Donna, et al.
Publicado: (2022)

COVID-19 infections and outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centers
por: Hultcrantz, Malin, et al.
Publicado: (2020)

Suboptimal Humoral and Cellular Immune Response to SARS-CoV-2 RNA Vaccination in Myeloma Patients Is Associated with Anti-CD38 and BCMA-Targeted Treatment
por: Van Oekelen, Oliver, et al.
Publicado: (2021)

COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers
por: Hultcrantz, Malin, et al.
Publicado: (2020)

Lack of health maintenance examinations and risk in myeloma patients
por: Tariman, Joseph D., et al.
Publicado: (2016)

The outcomes of newly diagnosed elderly multiple myeloma patients treated at a single U.S. institution
por: Bonomo, Lauren, et al.
Publicado: (2016)

Proteasome inhibition and its therapeutic potential in multiple myeloma
por: Chari, Ajai, et al.
Publicado: (2010)

Targeting Nuclear Export Proteins in Multiple Myeloma Therapy
por: Theodoropoulos, Nicholas, et al.
Publicado: (2020)

Incidence and risk of hypertension in patients newly treated for multiple myeloma: a retrospective cohort study
por: Chari, Ajai, et al.
Publicado: (2016)

Patient‐Reported Factors in Treatment Satisfaction in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
por: Chari, Ajai, et al.
Publicado: (2019)

Management of Patients With Hepatitis C Virus, Monoclonal Gammopathy of Undetermined Significance, and Multiple Myeloma
por: Hannaford, Alisse, et al.
Publicado: (2017)

Letter About: Risk Factors for Mortality in Patients with COVID-19 in New York City
por: Tleyjeh, Imad M., et al.
Publicado: (2021)

1741. Invasive Fungal Infections in Patients with Multiple Myeloma in the Era of Novel Therapies
por: Baneman, Emily, et al.
Publicado: (2019)

Obesity Prevention in a City State: Lessons from New York City during the Bloomberg Administration
por: Kelly, Paul M., et al.
Publicado: (2016)

P888: MATCHED-ADJUSTED INDIRECT COMPARISON OF TALQUETAMAB VS SELINEXOR-DEXAMETHASONE AND VS BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
por: Chari, Ajai, et al.
Publicado: (2023)

In Revered Memory of Prof. N.S. Vahia, M.D
por: Singh, Ajai
Publicado: (2008)

A Focus on Newly Diagnosed Multiple Myeloma
por: Brigle, Kevin, et al.
Publicado: (2022)

Cardiology Fellowship During the COVID-19 Pandemic: Lessons From New York City
por: Hadley, Michael B., et al.
Publicado: (2020)

Tracheostomy Outcomes in Patients With COVID-19 at a New York City Hospital
por: Sharma, Rahul K., et al.
Publicado: (2022)

Summer Heat and Mortality in New York City: How Hot Is Too Hot?
por: Metzger, Kristina B., et al.
Publicado: (2010)

B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches
por: Shah, Nina, et al.
Publicado: (2020)

York City Asylum
Publicado: (1907)

New York City
Publicado: (1896)

Obesity and Diabetes in New York City, 2002 and 2004
por: Van Wye, Gretchen, et al.
Publicado: (2008)

Risk Factors for Death Among Hospitalized Patients Aged 21–64 Years Diagnosed with COVID-19—New York City, March 13–April 9, 2020
por: Bushman, Dena, et al.
Publicado: (2021)

Effects of the COVID-19 Outbreak on Elder Mistreatment and Response in New York City: Initial Lessons
por: Elman, Alyssa, et al.
Publicado: (2020)

Lessons in flexibility from a general surgery program at the epicenter of the pandemic in New York City
por: Nobel, Tamar B., et al.
Publicado: (2020)

The Nation’s First Publicly Recognized Overdose Prevention Centers: Lessons Learned in New York City
por: Giglio, Rebecca E., et al.
Publicado: (2023)

Duration of frontline therapy and impact on clinical outcomes in newly diagnosed multiple myeloma patients not receiving frontline stem cell transplant
por: Ailawadhi, Sikander, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_778ma3m2f539i7hjlt8tt86aja